Windtree Therapeutics Plans $520 Million BNB Acquisition, Partners with Kraken
Nasdaq-listed biopharmaceutical company Windtree Therapeutics has announced plans to raise up to $520 million specifically for the acquisition of BNB tokens as part of a broader $700 million allocation towards BNB purchases. The company has selected Kraken, a major cryptocurrency… Read More »Windtree Therapeutics Plans $520 Million BNB Acquisition, Partners with Kraken